Endoscopic ultrasound-guided transesophageal thoracentesis by DeWitt, J. et al.
In a retrospective, single−center study, we
identified nine consecutive patients (six
male; median age 66 years; range 55± 79
years) who, between January 2003 and
April 2007, underwent attempted endo−
scopic ultrasound (EUS−)guided thora−
centesis into the right (n = 7) or left
(n = 2) pleural space. In all patients a di−
agnosis of cancer was made either prior
to (n = 6) or by (n = 3) EUS. Thoracentesis
was not the primary indication for EUS in
any patient. Right−sided thoracentesis
was performed when possible due to the
dependent position of the pleural fluid
relative to the right esophageal wall in
the left lateral decubitus position. Prior
to aspiration, no additional maneuvers
(i. e. patient breath hold) were performed.
Thoracentesis was successful in all pa−
tients, and a median of 12 mL (range
2.5 ± 36 mL) was aspirated without com−
plications. Pleural fluid cytology was po−
sitive for malignancy in two patients
(22 %): adenocarcinoma of unknown pri−
mary (n = 1) and metastatic ovarian ade−
nocarcinoma (n = 1). In both cases, EUS−
guided thoracentesis provided the initial
diagnosis of a malignant effusion
(l" Fig. 1 ± 4). Pleural fluid cytology in
each of the remaining seven was benign.
Following EUS, all patients were given
one dose of an intravenous antibiotic
(ampicillin/sulbactam or ciprofloxacin),
and a prescription for an additional 3 ±5
days of oral antibiotic treatment (amoxi−
cillin/clavulinic acid or ciprofloxacin).
Follow−up chest radiographic imaging
(median 3 months; range 1 ± 18 months)
in the seven with benign cytology
showed complete or near complete reso−
lution of all effusions.
Traditional thoracentesis using a percuta−
neous posterior approach without image
guidance may be associated with pneu−
mothoraces in approximately 10% of pa−
tients [1]. With sonographic guidance,
the rate of pneumothorax following diag−
nostic percutaneous thoracentesis re−
mains 2.5 % ± 5.5 % [2,3]. There are limited
data on the utility of EUS−guided thora−
centesis [4, 5]. Our series shows that EUS−
guided thoracentesis is technically feasi−
ble and safe, and may provide the initial
diagnosis of a malignant pleural effusion
in a subset of patients with previously
known or suspected cancer (l" Video 1).
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Fig. 2 Linear endo−
scopic ultrasound im−
age (6 MHz) of the
same patient showing
the pleural effusion
(PL EFF) between the
esophageal wall and
the right lung. The
pleura is demonstrated
as the hyperechoic line
between the pleural
fluid and the lung.
Fig. 1 Radial endo−
scopic ultrasound im−
age (7.5 MHz) of a right
pleural effusion (PL
EFF). LA, left atrium;
AO, aorta.
Video 1
A 66−year−old female with a history of ovarian
cancer and a new left pleural effusion under−
went endoscopic ultrasound−guided thora−
centesis for drainage of symptomatic retro−
peritoneal cyst causing early satiety. Cytology
from both the pleural fluid and cyst cavity
demonstrated metastatic adenocarcinoma.
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Fig. 3 Endoscopic
ultrasound−guided fine
needle aspiration of the
pleural effusion. The tip
of the needle is seen
within the pleural cav−
ity.
Fig. 4 Cohesive group
of pleomorphic cells
with large, eccentric
nuclei and centrally
located nucleoli consis−
tent with adenocarci−
noma (Papanicolau
stain;  100).
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